Cargando…

Nuchal translucency of 3.0‐3.4 mm an indication for NIPT or microarray? Cohort analysis and literature review

INTRODUCTION: Currently fetal nuchal translucency (NT) ≥3.5 mm is an indication for invasive testing often followed by chromosomal microarray. The aim of this study was to assess the risks for chromosomal aberrations in fetuses with an NT 3.0‐3.4 mm, to determine whether invasive prenatal testing wo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petersen, Olav B., Smith, Eric, Van Opstal, Diane, Polak, Marike, Knapen, Maarten F. C. M., Diderich, Karin E. M., Bilardo, Caterina M., Arends, Lidia R., Vogel, Ida, Srebniak, Malgorzata I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318216/ https://www.ncbi.nlm.nih.gov/pubmed/32306377 http://dx.doi.org/10.1111/aogs.13877

Ejemplares similares

Enlarged NT (≥3.5 mm) in the first trimester – not all chromosome aberrations can be detected by NIPT
por: Srebniak, Malgorzata I., et al.
Publicado: (2016)

Patient-friendly integrated first trimester screening by NIPT and fetal anomaly scan
por: Srebniak, Malgorzata Ilona, et al.
Publicado: (2021)

Social and medical need for whole genome high resolution NIPT
por: Srebniak, Malgorzata I., et al.
Publicado: (2019)

Prenatal Diagnostic Value of Chromosomal Microarray in Fetuses with Nuchal Translucency Greater than 2.5 mm
por: Zhang, Zhu, et al.
Publicado: (2019)

Chromosomal Microarray Analysis versus Karyotyping in Fetuses with Increased Nuchal Translucency
por: Cicatiello, Rita, et al.
Publicado: (2019)

Increased Nuchal Translucency and Pregnancy Outcome
por: Tahmasebpour, A, et al.
Publicado: (2012)

Fetal nuchal translucency scan in Nigeria
por: Oloyede, Olufemi Adebari, et al.
Publicado: (2014)

False Negative NIPT Results: Risk Figures for Chromosomes 13, 18 and 21 Based on Chorionic Villi Results in 5967 Cases and Literature Review
por: Van Opstal, Diane, et al.
Publicado: (2016)

Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening?
por: Bardi, Francesca, et al.
Publicado: (2019)

Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype
por: Su, Linjuan, et al.
Publicado: (2019)

Chromosomal microarray analysis versus noninvasive prenatal testing in fetuses with increased nuchal translucency
por: Wang, Chaohong, et al.
Publicado: (2022)

Distribution of nuchal translucency in antenatal screening for Down's syndrome
por: Bestwick, J P, et al.
Publicado: (2010)

Evaluation of Nuchal Translucency Measurement in First Trimester Pregnancy
por: Barati, Mojgan, et al.
Publicado: (2011)

Simplified protocol of nuchal translucency measurement: Is it still effective?
por: Kim, Sun Min, et al.
Publicado: (2013)

Distribution of nuchal translucency in antenatal screening for Down's syndrome
Publicado: (2010)

Fetal nuchal translucency: is there an association with birthweight and neonatal wellbeing?
por: Kalem, Ziya, et al.
Publicado: (2019)

Placental studies elucidate discrepancies between NIPT showing a structural chromosome aberration and a differently abnormal fetal karyotype
por: Van Opstal, Diane, et al.
Publicado: (2019)

The Distribution of Fetal Nuchal Translucency Thickness in Normal Korean Fetuses
por: Chung, Jin-Hoon, et al.
Publicado: (2004)

Detection of Fetal Abnormalities Based on Three Dimensional Nuchal Translucency
por: Lai, Khin Wee, et al.
Publicado: (2013)

The effect of progesterone use in the first trimester on fetal nuchal translucency
por: Namlı Kalem, Müberra, et al.
Publicado: (2018)

Clinical significance of nuchal translucency measurement in routine prenatal examination
por: Zhao, Xin-Rong, et al.
Publicado: (2021)

Ultrasonography of the nuchal translucency of healthy and abnormal English Bulldog fetuses
por: Pavan, Letícia, et al.
Publicado: (2021)

Effect of Exogenous Progesterone on Fetal Nuchal Translucency: An Observational Study
por: Bagde, Nilajkumar D, et al.
Publicado: (2022)

Pregnancy outcomes of normal karyotype fetuses with increased nuchal translucency
por: Niroomanesh, Shirin, et al.
Publicado: (2023)

Prenatal whole‐exome sequencing in fetuses with increased nuchal translucency
por: Cao, Chunge, et al.
Publicado: (2023)

Analysis of Quality of Nuchal Translucency Measurements: Its Role in Prenatal Diagnosis
por: Gabriel, Carmen Comas, et al.
Publicado: (2011)

Isolated Increased Nuchal Translucency in First Trimester Ultrasound Scan: Diagnostic Yield of Prenatal Microarray and Outcome of Pregnancy
por: Stuurman, Kyra E., et al.
Publicado: (2021)

Prenatal Diagnosis of Fetuses With Increased Nuchal Translucency by Genome Sequencing Analysis
por: Choy, Kwong Wai, et al.
Publicado: (2019)

The value of screening for major fetal abnormalities during the nuchal translucency examination
por: Wye, Deborah, et al.
Publicado: (2015)

Analysis of copy number variation by sequencing in fetuses with nuchal translucency thickening
por: Lan, Liubing, et al.
Publicado: (2020)

Prenatal diagnosis of Pfeiffer syndrome type 2 with increased nuchal translucency
por: Hu, Zhi‐yang, et al.
Publicado: (2021)

Increased nuchal translucency before 11 weeks of gestation: Reason for referral?
por: Lugthart, Malou A., et al.
Publicado: (2021)

Threshold of Nuchal Translucency for the Detection of Chromosomal Aberration: Comparison of Different Cut-offs
por: Kim, Min-Hyoung, et al.
Publicado: (2006)

Image Settings Affecting Nuchal Translucency Measurement Using Volume NT™ Software
por: Cho, Hee Young, et al.
Publicado: (2015)

Increased nuchal translucency and pregnancy outcomes: experience of Başkent University Ankara Hospital
por: Şahin Uysal, Nihal, et al.
Publicado: (2019)

Fetal exome sequencing for isolated increased nuchal translucency: should we be doing it?
por: Mellis, R, et al.
Publicado: (2021)

Prenatal diagnosis and early childhood outcome of fetuses with extremely large nuchal translucency
por: Zhou, Hang, et al.
Publicado: (2023)

High Frequency of Fetal Loss in Fetuses With Normal Karyotype and Nuchal Translucency ≥ 3 Among the Iranian Pregnant Women
por: Abotorabi, Shokoh, et al.
Publicado: (2020)

Incidence of major structural cardiac defects in fetuses with increased nuchal translucency and normal karyotype
por: Praprotnik, K, et al.
Publicado: (2013)

Do the Levels of Maternal Plasma Trace Elements Affect Fetal Nuchal Translucency Thickness?
por: Liao, Kai-Wei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0u0p3qq8m2hicaa4v5ara5umvm